Baohui Han: Clinical Trials

6 trials sponsored by Baohui Han, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Unknown 1
Not applicable1Completed 1
Phase 11Not yet recruiting 1

Follow Baohui Han: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC
This study did not include intervention between the two cohorts - Non-Small Cell Lung Cancer
RecruitingBaohui Han5082025-03-012025-02-26
Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
This study did not include intervention between two cohorts - Lung Cancer (Diagnosis), Fragmentomics
RecruitingBaohui Han2402024-08-212026-02-10
Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
Adebrelimab, Irinotecan Liposome (II), Adebrelimab, Irinotecan Liposome (II), Famitinib - Extensive-stage Small-cell Lung Cancer
Phase 1 / Phase 2Not yet recruitingBaohui Han802024-04-012024-03-27
Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns
Aumolertinib - Lung Cancer
Phase 2UnknownBaohui Han1042022-01-142023-04-21
Combination of Chemotherapy and Gefitinib as First-line Treatment
pemetrexed plus carboplatin, gefitinib - Non-Small-Cell Lung Cancer
Not applicableCompletedBaohui Han1212014-05-012016-04-20
Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.
erlotinib - Non Small Cell Lung Cancer
Phase 2CompletedBaohui Han252011-03-022017-09-12

Conditions studied

Carcinoma, Non-Small-Cell Lung (3)  ·  Lung Neoplasms (2)  ·  Disease (1)  ·  Small Cell Lung Carcinoma (1)

Interventions

Carboplatin (1)  ·  Erlotinib Hydrochloride (1)  ·  Gefitinib (1)  ·  Pemetrexed (1)  ·  aumolertinib (1)  ·  famitinib (1)  ·  irinotecan sucrosofate (1)

Countries

China (6)

Top investigators

Aiqin Gu, Master (1)  ·  Bo Jin, Dr (1)  ·  Jun Pei (1)  ·  Lei Zhu, Master (1)  ·  Tianqing Chu, Dr (1)  ·  Yanjie Niu, Master (1)  ·  Yanwei Zhang, Dr (1)

Results publications

PMID 30158288, PMID 31885349, PMID 32170554